Guenther Hochhaus - Publications

Affiliations: 
University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Pharmaceutical Chemistry
Website:
https://pharmacy.ufl.edu/faculty/guenther-hochhaus/

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sun W, Zhou D, Warner JH, Langbehn DR, Hochhaus G, Wang Y. Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales. Journal of Clinical Pharmacology. PMID 32416008 DOI: 10.1002/Jcph.1598  0.593
2020 Shao J, Talton J, Wang Y, Winner L, Hochhaus G. Quantitative Assessment of Pulmonary Targeting of Inhaled Corticosteroids Using Ex Vivo Receptor Binding Studies. The Aaps Journal. 22: 39. PMID 32002694 DOI: 10.1208/S12248-019-0404-0  0.344
2019 Shao J, Chen MJ, Kuehl PJ, Hochhaus G. Pharmacokinetic and pharmacodynamic modeling of gut hormone peptide YY after pulmonary delivery. Drug Development and Industrial Pharmacy. 1-10. PMID 31039626 DOI: 10.1080/03639045.2019.1593443  0.356
2016 Hastedt JE, Bäckman P, Clark AR, Doub W, Hickey A, Hochhaus G, Kuehl PJ, Lehr C, Mauser P, McConville J, Niven R, Sakagimi M, Weers JG. Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD Aaps Open. 2. DOI: 10.1186/S41120-015-0002-X  0.35
2015 Weber B, Hochhaus G. A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation Approach. The Aaps Journal. 17: 999-1010. PMID 25933600 DOI: 10.1208/S12248-015-9768-Y  0.324
2013 Sun W, Laughren TP, Zhu H, Hochhaus G, Wang Y. Development of a placebo effect model combined with a dropout model for bipolar disorder. Journal of Pharmacokinetics and Pharmacodynamics. 40: 359-68. PMID 23456101 DOI: 10.1007/S10928-013-9305-5  0.597
2013 Weber B, Hochhaus G. A pharmacokinetic simulation tool for inhaled corticosteroids. The Aaps Journal. 15: 159-71. PMID 23139018 DOI: 10.1208/S12248-012-9420-Z  0.327
2012 Haug KG, Weber B, Hochhaus G, Butterweck V. Pharmacokinetic evaluation of visnagin and Ammi visnaga aqueous extract after oral administration in rats. Planta Medica. 78: 1831-6. PMID 23096256 DOI: 10.1055/S-0032-1315393  0.402
2012 Haug KG, Weber B, Hochhaus G, Butterweck V. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 45: 79-89. PMID 22085634 DOI: 10.1016/J.Ejps.2011.10.023  0.333
2010 Pinto E, Zhang B, Song S, Bodor N, Buchwald P, Hochhaus G. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant Pharmazie. 65: 429-435. PMID 20614691 DOI: 10.1691/Ph.2010.0033R  0.305
2010 Afzal A, Caballero S, Palii SS, Jurczyk S, Pardue M, Geroski D, Edelhauser H, Hochhaus G, Kim M, Franklin A, Shapiro G, Grant MB. Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole. Brain Research Bulletin. 81: 320-6. PMID 19679174 DOI: 10.1016/J.Brainresbull.2009.08.001  0.309
2009 Wu K, Blomgren AL, Ekholm K, Weber B, Edsbaecker S, Hochhaus G. Budesonide and ciclesonide: Effect of tissue binding on pulmonary receptor binding Drug Metabolism and Disposition. 37: 1421-1426. PMID 19364829 DOI: 10.1124/Dmd.108.026039  0.343
2008 Wu K, Goyal N, Stark JG, Hochhaus G. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach. Journal of Clinical Pharmacology. 48: 1069-80. PMID 18728243 DOI: 10.1177/0091270008320607  0.732
2008 Coowanitwong I, Arya V, Kulvanich P, Hochhaus G. Slow release formulations of inhaled rifampin. The Aaps Journal. 10: 342-8. PMID 18584334 DOI: 10.1208/S12248-008-9044-5  0.742
2008 Goyal N, Hochhaus G. Fluticasone furoate nasal spray in allergic rhinitis. Drugs of Today (Barcelona, Spain : 1998). 44: 251-60. PMID 18536783 DOI: 10.1358/Dot.2008.44.4.1173289  0.345
2007 Coowanitwong I, Arya V, Patel G, Kim WS, Craciun V, Rocca JR, Singh R, Hochhaus G. Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics. The Journal of Pharmacy and Pharmacology. 59: 1473-84. PMID 17976257 DOI: 10.1211/Jpp.59.11.0003  0.742
2006 Arya V, Coowanitwong I, Brugos B, Kim WS, Singh R, Hochhaus G. Pulmonary targeting of sustained release formulation of budesonide in neonatal rats. Journal of Drug Targeting. 14: 680-6. PMID 17162737 DOI: 10.1080/10611860601010314  0.759
2006 Mortimer KJ, Harrison TW, Tang Y, Wu K, Lewis S, Sahasranaman S, Hochhaus G, Tattersfield AE. Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma. British Journal of Clinical Pharmacology. 62: 412-9. PMID 16995862 DOI: 10.1111/J.1365-2125.2006.02712.X  0.656
2006 Stark JG, Werner S, Homrighausen S, Tang Y, Krieg M, Derendorf H, Moellmann H, Hochhaus G. Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide. Journal of Pharmacokinetics and Pharmacodynamics. 33: 441-59. PMID 16633890 DOI: 10.1007/S10928-006-9013-5  0.693
2006 Issar M, Sahasranaman S, Buchwald P, Hochhaus G. Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. The European Respiratory Journal. 27: 511-6. PMID 16507850 DOI: 10.1183/09031936.06.00060005  0.679
2006 Arya V, Demarco VG, Issar M, Hochhaus G. Contrary to adult, neonatal rats show pronounced brain uptake of corticosteroids. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 939-42. PMID 16507650 DOI: 10.1124/Dmd.105.007419  0.666
2006 Sahasranaman S, Issar M, Hochhaus G. Metabolism of mometasone furoate and biological activity of the metabolites. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 225-33. PMID 16251254 DOI: 10.1124/Dmd.105.005702  0.659
2005 Arya V, Issar M, Wang Y, Talton JD, Hochhaus G. Brain permeability of inhaled corticosteroids. The Journal of Pharmacy and Pharmacology. 57: 1159-67. PMID 16105236 DOI: 10.1211/Jpp.57.9.0010  0.657
2005 Sahasranaman S, Tang Y, Biniasz D, Hochhaus G. A sensitive liquid chromatography-tandem mass spectrometry method for the quantification of mometasone furoate in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 819: 175-9. PMID 15797536 DOI: 10.1016/J.Jchromb.2005.01.018  0.655
2004 Brugos B, Arya V, Hochhaus G. Stabilized dynorphin derivatives for modulating antinociceptive activity in morphine tolerant rats: effect of different routes of administration. The Aaps Journal. 6: e36. PMID 15760101 DOI: 10.1208/Aapsj060436  0.665
2004 Kolkman JJ, Möllmann HW, Möllmann AC, Penã AS, Greinwald R, Tauschel HD, Hochhaus G. Evaluation of oral budesonide in the treatment of active distal ulcerative colitis. Drugs of Today (Barcelona, Spain : 1998). 40: 589-601. PMID 15510233 DOI: 10.1358/Dot.2004.40.7.850477  0.314
2004 Al-Fayoumi SI, Brugos B, Arya V, Mulder E, Eppler B, Mauderli AP, Hochhaus G. Identification of stabilized dynorphin derivatives for suppressing tolerance in morphine-dependent rats. Pharmaceutical Research. 21: 1450-6. PMID 15359581 DOI: 10.1023/B:Pham.0000036920.50291.5B  0.628
2004 Sahasranaman S, Issar M, Tóth G, Horváth G, Hochhaus G. Characterization of degradation products of mometasone furoate. Die Pharmazie. 59: 367-73. PMID 15212303  0.643
2004 Nunan EA, Arya V, Hochhaus G, Cardoso VN, Moraes-Santos T. Age effects on the pharmacokinetics of tityustoxin from Tityus serrulatus scorpion venom in rats. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas MéDicas E BiolóGicas / Sociedade Brasileira De BiofíSica ... [Et Al.]. 37: 385-90. PMID 15060708 DOI: 10.1590/S0100-879X2004000300016  0.625
2004 Asmus MJ, Liang J, Coowanitwong I, Hochhaus G. In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler. Pharmacotherapy. 24: 159-66. PMID 14998215 DOI: 10.1592/Phco.24.2.159.33147  0.777
2004 Issar M, Sahasranaman S, Hochhaus G. Differences in selectivity of inhaled glucocorticoids (IGCs) to the glucocorticoid receptors (GR) The Journal of Allergy and Clinical Immunology. 113. DOI: 10.1016/J.Jaci.2003.12.415  0.674
2004 Sahasranaman S, Issar M, Toth G, Horvath G, Hochhaus G. Degradation of mometasone furoate in the lung The Journal of Allergy and Clinical Immunology. 113. DOI: 10.1016/J.Jaci.2003.12.404  0.678
2003 Asmus MJ, Coowanitwong I, Kwon SH, Khorsand N, Hochhaus G. In vitro performance of two common valved holding chambers with a chlorofluorocarbon-free beclomethasone metered-dose inhaler. Pharmacotherapy. 23: 1538-44. PMID 14695033 DOI: 10.1592/Phco.23.15.1538.31960  0.793
2003 Hochhaus G, Brookman L, Fox H, Johnson C, Matthews J, Ren S, Deniz Y. Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma. Current Medical Research and Opinion. 19: 491-8. PMID 14594521 DOI: 10.1185/030079903125002171  0.335
2003 Taylor SA, Asmus MJ, Liang J, Coowanitwong I, Vafadari R, Hochhaus G. Performance of a corticosteroid inhaler with a spacer fashioned from a plastic cold-drink bottle: effects of changing bottle volume. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 40: 237-42. PMID 12807166 DOI: 10.1081/Jas-120018712  0.785
2003 Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen BK, Barrett JS. Population pharmacokinetics and pharmacodynamics of ciclesonide. Journal of Clinical Pharmacology. 43: 365-78. PMID 12723457 DOI: 10.1177/0091270002250998  0.65
2003 Asmus MJ, Wu K, Arya V, Hochhaus G. In Vitro Comparison of Fluticasone Respirable Dose From a Metered-Dose Inhaler and Three Ridged Valved Holding Chamber Chest. 124: 137S. DOI: 10.1378/Chest.124.4_Meetingabstracts.137S-B  0.695
2003 Asmus MJ, Arya V, Hochhaus G. An In Vitro Comparison of Two Non-Electrostatic Valved Holding Chambers With a Fluticasone Metered-Dose Inhale Chest. 124: 106S. DOI: 10.1378/Chest.124.4_Meetingabstracts.106S-A  0.692
2003 Amerman C, Asmus M, Issar M, Arya V, Coowanitwong I, Hochhaus G. Effects of valved holding chamber electrostatic charge on delivery of beclomethasone dipropionate from a hydrofluoroalkane metered dose inhaler Journal of Allergy and Clinical Immunology. 111: S126. DOI: 10.1016/S0091-6749(03)80387-1  0.759
2002 Asmus MJ, Liang J, Coowanitwong I, Vafadari R, Hochhaus G. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 88: 204-8. PMID 11868926 DOI: 10.1016/S1081-1206(10)61997-7  0.788
2002 Rohatagi S, Arya V, Zech K, Barrett JS, Hochhaus G, Jensen BK. Population pharmacokinetics/pharmacodynamics of ciclesonide Journal of Allergy and Clinical Immunology. 109: S236-S236. DOI: 10.1016/S0091-6749(02)81851-6  0.629
2001 Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects. Journal of Clinical Pharmacology. 41: 1329-38. PMID 11762560 DOI: 10.1177/00912700122012913  0.772
2001 Derendorf H, Hochhaus G, Möllmann H. Evaluation of pulmonary absorption using pharmacokinetic methods Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung. 14. PMID 11424896 DOI: 10.1089/08942680150506295  0.335
2000 Krishnaswami S, Hochhaus G, Derendorf H. An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy. Aaps Pharmsci. 2: E22. PMID 11741238 DOI: 10.1208/Ps020322  0.419
1999 Müller S, Hutson A, Arya V, Hochhaus G. Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches: the metabolism of dynorphin A1-13 and related fragments in human plasma. Journal of Pharmaceutical Sciences. 88: 938-44. PMID 10479358 DOI: 10.1021/Js980036D  0.614
1997 Rohatagi S, Barth J, Möllmann H, Hochhaus G, Soldner A, Möllmann C, Derendorf H. Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration Journal of Clinical Pharmacology. 37: 916-925. PMID 9505983 DOI: 10.1002/J.1552-4604.1997.Tb04266.X  0.31
1996 Gonzalez-Rothi RJ, Suarez S, Hochhaus G, Schreier H, Lukyanov A, Derendorf H, Dalla Costa T. Pulmonary targeting of liposomal triamcinolone acetonide phosphate Pharmaceutical Research. 13: 1699-1703. PMID 8956337 DOI: 10.1023/A:1016448908909  0.354
1991 Ratka A, Hochhaus G, Wissler RN, Simpkins JW. cAMP accumulation in opioid-sensitive SH-SY5Y neuroblastoma cells is modified by estradiol and progesterone. Molecular and Cellular Endocrinology. 78: 155-62. PMID 1663875 DOI: 10.1016/0303-7207(91)90118-C  0.305
1988 Hochhaus G, Sadée W. A Biotin–Avidin-Based Enzyme Immunoassay for βh-Endorphin Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 5: 232-235. PMID 2977649 DOI: 10.1023/A:1015993713471  0.427
1988 Hochhaus G, Patthy A, Schwietert R, Santi DV, Sadée W. [Biocytin13]Dynorphin A 1-13 Amide: A Potential Probe for the κ-Opioid Receptor Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 5: 790-794. PMID 2907785 DOI: 10.1023/A:1015944903360  0.418
1988 Sadee W, Yu VC, Hochhaus G. Effects of opioid peptides on human neuroblastoma cells Nida Research Monograph Series. 111-117. PMID 2855093  0.383
1988 Preis PN, Saya H, Nadasdi L, Hochhaus G, Levin V, Sadee W. Neuronal Cell Differentiation of Human Neuroblastoma Cells by Retinoic Acid plus Herbimycin A Cancer Research. 48: 6530-6534. PMID 2846152  0.385
1988 Hochhaus G, Gibson BW, Sadee W. Biotinylated human β-endorphins as probes for the opioid receptor Journal of Biological Chemistry. 263: 92-97. PMID 2826453  0.421
1986 Hochhaus G, Yu VC, Sadée W. Delta opioid receptor in human neuroblastoma cell lines Brain Research. 382: 327-331. PMID 3019481 DOI: 10.1016/0006-8993(86)91341-7  0.4
1986 Hochhaus G, Gibson BW, Sadée W. Development of a biotin-avidin probe for detecting opioid receptors Nida Research Monograph. 75: 33-36. PMID 2828982  0.405
Show low-probability matches.